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The operative time it takes to recon-
struct the pericardium is not significant,
and the diaphragmatic reconstruction is not
facilitated in our experience by leaving the
pericardium in.
Finally, we agree that personal experi-
ence with chylothorax should guide each
surgeon as to whether prophylactic thoracic
duct ligation should be used routinely.
Lambros Zellos, MD
David J. Sugarbaker, MD
Department of Thoracic Surgery
Brigham and Women’s Hospital
Boston, MA 02115-6195
doi:10.1016/j.jtcvs.2004.11.047
Technique for microsphere injection
To the Editor:
We read with great interest the article by
Hedayati and associates1 recently pub-
lished in the Journal. The authors sug-
gested that axillary artery cannulation for
cardiopulmonary bypass is cerebroprotec-
tive from aortic atheroemboli by using ca-
nine models. We respectfully would like to
note some procedural inconsistencies that
might have lead to bias in the authors’
conclusions.
The authors assessed the distribution of
microspheres simulating aortic atheroem-
boli shed by patients during cardiopulmo-
nary bypass. However, the microsphere in-
jection method was inconsistent (eg, the
pump flow was not constant, and the rate of
microsphere injection was unclear), and the
reference blood withdrawal rate for calcu-
lating tissue blood flow was unclear. Be-
cause the distribution pattern of the micro-
spheres can be influenced easily by the
pump flow rate, microsphere injection rate,
shape of the aorta, and location of the in-
jection, more precise experimental proto-
cols might affect this study’s results.
One more point of concern in this study
is the size of the microspheres. Small mi-
crospheres (15 m in diameter) have been
used for measuring tissue blood flow,2 and
large microspheres (50 m in diameter)
have been used for creating microemboli3
by several investigators. Hedayati and
associates1 used microspheres 15 m in
diameter; however, they did not use the
microspheres to measure tissue blood flow
but rather as microemboli in this study.
Because atheroemboli are generally larger
than 15 m in diameter and because size
affects the degree of cerebral ischemia and
infarction,4 we believe that the larger mi-
crosphere should have been used to analyze
the risk of atheroemboli in the aorta during
cardiopulmonary bypass.
In light of these considerations, the au-
thors’ conclusion that “axillary artery can-
nulation for cardiopulmonary bypass is ce-
rebroprotective” cannot be fully supported
on the basis of the data presented. More
studies with larger microspheres or flow
characterization with both particle image
velocimetry and laser Doppler velocimetry
could provide more meaningful results and
insights on this subject to further under-
stand this clinically important topic.
Yoshio Ootaki, MD, PhD
Kiyotaka Fukamachi, MD, PhD
Department of Biomedical Engineering
Lerner Research Institute
The Cleveland Clinic Foundation
Cleveland, OH 44195
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Reply to the Editor:
Thank you for your interest in our publica-
tion entitled “Axillary artery cannulation
for cardiopulmonary bypass reduces cere-
bral microemboli.” We are confident that
our conclusion, that axillary cannulation
reduces cerebral microemboli, is supported
by our experimental evidence. We apolo-
gize for any lack of clarity with our exper-
imental design. We agree that the distribu-
tion pattern of the microspheres might be
influenced by the pump flow rate, micro-
sphere injection rate, shape of the aorta,
location of the injection, and location of the
cardiopulmonary bypass cannulation site.
Using each animal as its own control en-
abled us to provide constant conditions for
each variable, with the only difference be-
ing the cannulation site.
Our microsphere injection method
was consistent for each animal. The only
variable was the cannulation site for car-
diopulmonary bypass. The pump flow
rate was constant during the 2 cannula-
tion techniques within each animal, al-
though the pump rate did vary from 1.9 to
3.4 L · min 1 · m 2 among animals to
maintain constant pressure among ani-
mals. Five million microspheres (2.5 
106 microspheres/mL) were injected over
1 minute.
Larger microspheres have been used to
induce infarction or ischemia and might
have been preferred if that was our inten-
tion. We were exclusively interested in the
distribution of the spheres and found no
evidence that the distribution of 50-m
spheres would have, in our model, altered
our impressive results. Atheroemboli range
in size, with the most numerous being the
smallest.1 We used 15-m spheres, as has
been done before in similar investigations.2
We agree with your suggestion that fur-
ther characterization of the flow pattern
through particle-imaging techniques will
provide additional evidence as to the supe-
rior ability of axillary cannulation to pro-
vide cerebroprotection, and we plan to do
so in the future to further corroborate the
vastly reduced stroke rate we have ob-
served when axillary perfusion was used in
our patients with high-risk aortas.
Steve J. Schomisch, BS
Alan H. Markowitz, MD
University Hospitals of Cleveland
Cardiothoracic Surgery
11,100 Euclid Ave
Cleveland, OH 44106
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Carbodissection of the internal
thoracic artery
To the Editor:
I write with reference to the article by
Özkan and associates titled “A Carbon Di-
oxide Insufflation Technique for Prepara-
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